Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 6/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | RARB | P10826 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL313840 | 0.91 | HCAR2 (0.53) | HCAR2ATMTSHRHPGDALDH1A1 | |
| Methacrylic Acid SCHEMBL10348380 | 0.90 | TSHR (0.48) | HCAR2THRBTSHR | |
| SCHEMBL7617323 | 0.88 | THRB (0.39) | HCAR2THRBATMTSHR | |
| SCHEMBL7739132 | 0.87 | TSHR (0.54) | HCAR2THRBATMTSHRHPGD | |
| SCHEMBL325215 | 0.87 | HCAR2 (0.54) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL10347496 | 0.85 | HCAR2 (0.55) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL6060612 | 0.85 | HCAR2 (0.55) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL9299634 | 0.85 | HCAR2 (0.55) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL121143 | 0.85 | HCAR2 (0.55) | HCAR2ATMTSHRHPGDALDH1A1 | |
| SCHEMBL10347220 | 0.85 | HCAR2 (0.50) | HCAR2THRBATMTSHRHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11578205-B2 | Antimicrobial, non-thrombogenic polymer composition | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2023-02-14 | — | — | US | disclosed |
| EP-3361868-B1 | BIOCIDALLY ACTIVE POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MAT INC (US) | 2021-12-15 | — | — | EP | disclosed |
| US-20210277231-A1 | Antimicrobial, Non-Thrombogenic Polymer Composition | LUBRIZOL ADVANCED MAT INC (US) | 2021-09-09 | — | — | US | disclosed |
| US-10829606-B2 | Surface modified polymer compositions | LUBRIZOL ADVANCED MATERIALS, INC. | 2020-11-10 | — | — | US | disclosed |
| US-10827757-B2 | Biocidally active polymer compositions | LUBRIZOL ADVANCED MATERIALS, INC. | 2020-11-10 | — | — | US | disclosed |
| EP-3285818-B1 | SURFACE MODIFIED POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MATERIALS INC (US) | 2020-09-23 | — | — | EP | disclosed |
| US-20190191703-A1 | BIOCIDALLY ACTIVE POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MATERIALS, INC. | 2019-06-27 | — | — | US | disclosed |
| EP-3361868-A1 | BIOCIDALLY ACTIVE POLYMER COMPOSITIONS | Lubrizol Advanced Materials, Inc. (US) | 2018-08-22 | — | — | EP | disclosed |
| WO-2018140911-A1 | ANTIMICROBIAL, NON-THROMBOGENIC POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2018-08-02 | — | — | WO | disclosed |
| US-20180105665-A1 | SURFACE MODIFIED POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MATERIALS, INC. | 2018-04-19 | — | — | US | disclosed |
| EP-3285818-A1 | SURFACE MODIFIED POLYMER COMPOSITIONS | Lubrizol Advanced Materials, Inc. (US) | 2018-02-28 | — | — | EP | disclosed |
| WO-2017066242-A1 | BIOCIDALLY ACTIVE POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2017-04-20 | — | — | WO | disclosed |
| WO-2016172460-A1 | SURFACE MODIFIED POLYMER COMPOSITIONS | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2016-10-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190191703-A1 | BIOCIDALLY ACTIVE POLYMER COMPOSITIONS | PUF60, FGB, PARG | HCAR2 4424/4885THRB 3659/4885ATM 3347/4885 |
| US-10827757-B2 | Biocidally active polymer compositions | PUF60, FGB, PARG | HCAR2 4424/4885THRB 3659/4885ATM 3347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.